Brii Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,508	1,003	489.65	1,191	2,855	1,035
Short-Term Investments	567.24	1,317	2,171	1,807	499.65	20
Cash & Short-Term Investments	2,075	2,320	2,661	2,997	3,355	1,055
Cash Growth	-13.07%	-12.79%	-11.23%	-10.65%	217.99%	19.83%
Other Receivables	-	-	71.09	57.72	51.52	24.8
Receivables	-	-	71.09	57.72	51.52	24.8
Other Current Assets	14.43	93.81	51.03	21.79	7.68	13.08
Total Current Assets	2,089	2,414	2,783	3,077	3,414	1,093
Property, Plant & Equipment	11.25	14.3	5.61	19.52	33.44	43.92
Long-Term Investments	7.04	9.2	142.44	146.03	152.03	116.55
Other Intangible Assets	303.53	179.71	267.42	146.89	9.51	12.22
Other Long-Term Assets	74.3	89.3	-	2.51	2.79	2.41
Total Assets	2,485	2,707	3,198	3,392	3,612	1,268
Accrued Expenses	23.46	52.94	68.63	150.87	205.83	486.67
Current Portion of Leases	4.52	4.9	3.16	9.5	8.97	8.02
Current Income Taxes Payable	1.13	1.19	2.01	1.86	1.65	1.02
Current Unearned Revenue	16.25	16.94	50.63	54.68	52.88	69.82
Other Current Liabilities	3.25	1.46	1.44	12.2	11.38	9.7
Total Current Liabilities	48.61	77.42	125.87	229.11	280.71	575.24
Long-Term Debt	-	17.97	-	-	-	2,403
Long-Term Leases	2.87	5.15	-	3.16	12.65	20.31
Long-Term Unearned Revenue	-	-	-	2.08	7.08	12.08
Total Liabilities	51.48	100.55	125.87	234.35	300.44	3,011
Common Stock	0.02	0.02	0.02	0.02	0.02	0.01
Additional Paid-In Capital	9,393	9,390	9,377	9,352	9,317	74.33
Retained Earnings	-7,398	-7,205	-6,697	-6,522	-6,038	-1,874
Treasury Stock	-16.9	-	-0.07	-	-	-
Comprehensive Income & Other	507.65	472.27	439.28	364.69	63.71	61.42
Total Common Equity	2,485	2,657	3,119	3,195	3,343	-1,738
Minority Interest	-51.66	-50.88	-46.66	-37.12	-31.65	-4.41
Shareholders' Equity	2,434	2,606	3,072	3,157	3,311	-1,743
Total Liabilities & Equity	2,485	2,707	3,198	3,392	3,612	1,268
Total Debt	7.39	28.02	3.16	12.66	21.62	2,431
Net Cash (Debt)	2,067	2,292	2,658	2,985	3,333	-1,376
Net Cash Growth	-12.66%	-13.74%	-10.96%	-10.45%	-	-
Net Cash Per Share	2.84	3.14	3.65	4.13	7.59	-7.20
Filing Date Shares Outstanding	719.33	731.31	729.39	727.2	720.29	706.2
Total Common Shares Outstanding	719.33	731.31	729.39	727.2	720.29	108.65
Working Capital	2,041	2,337	2,657	2,848	3,133	517.61
Book Value Per Share	3.46	3.63	4.28	4.39	4.64	-16.00
Tangible Book Value	2,182	2,477	2,852	3,048	3,333	-1,751
Tangible Book Value Per Share	3.03	3.39	3.91	4.19	4.63	-16.11
Machinery	-	3.71	0.34	0.34	0.34	0.34
Leasehold Improvements	-	24.84	24.84	24.84	24.84	23.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.